| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A practical approach to the pharmacological management of hypertension in older people
|
Parekh, Nikesh
|
|
2017
|
|
4 |
p. 117-132
|
artikel
|
| 2 |
A study on drug–drug interactions through prescription analysis in a South Indian teaching hospital
|
Kulkarni, Vijay
|
|
2013
|
|
4 |
p. 141-146
|
artikel
|
| 3 |
Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors
|
Onitilo, Adedayo A.
|
|
2014
|
|
4 |
p. 154-166
|
artikel
|
| 4 |
Diabetes and cardiovascular disease: focus on glucagon-like peptide-1 based therapies
|
Stranges, Paul
|
|
2012
|
|
4 |
p. 185-201
|
artikel
|
| 5 |
Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats
|
Akintunde, Jacob K.
|
|
2016
|
|
4 |
p. 132-146
|
artikel
|
| 6 |
Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies
|
de Jong, Marlies R.
|
|
2013
|
|
4 |
p. 147-154
|
artikel
|
| 7 |
High-risk prescribing and monitoring in primary care: how common is it, and how can it be improved?
|
Dreischulte, Tobias
|
|
2012
|
|
4 |
p. 175-184
|
artikel
|
| 8 |
Impact of prescribed medications on patient safety in older people
|
Anathhanam, Sujo
|
|
2012
|
|
4 |
p. 165-174
|
artikel
|
| 9 |
Incidence of health insurance claims for thyroid neoplasm and pancreatic malignancy in association with exenatide: signal refinement using active safety surveillance
|
Dore, David D.
|
|
2012
|
|
4 |
p. 157-164
|
artikel
|
| 10 |
Making rational choices about how best to support consumers’ use of medicines: a perspective review
|
Ryan, Rebecca
|
|
2016
|
|
4 |
p. 159-164
|
artikel
|
| 11 |
Medication-overuse headache: a perspective review
|
Westergaard, Maria Lurenda
|
|
2016
|
|
4 |
p. 147-158
|
artikel
|
| 12 |
Moxifloxacin-induced tinnitus in an older adult
|
Onoh, Amber
|
|
2018
|
|
4 |
p. 219-221
|
artikel
|
| 13 |
New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?
|
French, Jacqueline A.
|
|
2011
|
|
4 |
p. 141-158
|
artikel
|
| 14 |
Nonmedical prescribing: where are we now?
|
Cope, Louise C.
|
|
2016
|
|
4 |
p. 165-172
|
artikel
|
| 15 |
Pharmacogenetic testing: current evidence of clinical utility
|
Moaddeb, Jivan
|
|
2013
|
|
4 |
p. 155-169
|
artikel
|
| 16 |
Posterior reversible encephalopathy syndrome with colitis in a patient treated with panitumumab
|
Blaye, Céline
|
|
2017
|
|
4 |
p. 133-136
|
artikel
|
| 17 |
Primary prevention of neural-tube defects and some other congenital abnormalities by folic acid and multivitamins: history, missed opportunity and tasks
|
Czeizel, Andrew E.
|
|
2011
|
|
4 |
p. 173-188
|
artikel
|
| 18 |
Proton pump inhibitors and risk of readmission and mortality in older patients discharged from a tertiary hospital to residential aged care facilities
|
Pegoli, Matthew A.
|
|
2017
|
|
4 |
p. 137-139
|
artikel
|
| 19 |
Quantifying nonsteroidal anti-inflammatory drug (NSAID) risk: can combining the evidence with the use of a network meta-analysis provide a solution?
|
Woodman, Richard John
|
|
2011
|
|
4 |
p. 137-139
|
artikel
|
| 20 |
Safety of antiobesity drugs
|
Cheung, Bernard Man Yung
|
|
2013
|
|
4 |
p. 171-181
|
artikel
|
| 21 |
Safety of drugs used in the treatment of osteoporosis
|
McGreevy, Cora
|
|
2011
|
|
4 |
p. 159-172
|
artikel
|
| 22 |
Spontaneously reported adverse drug events related to tapentadol and oxycodone/naloxone in Australia
|
Abeyaratne, Carmen
|
|
2018
|
|
4 |
p. 197-205
|
artikel
|
| 23 |
The consequences of nonprescription medication sales in Saudi Arabia’s community pharmacies: regulations without implementation
|
Khan, Tahir M.
|
|
2014
|
|
4 |
p. 173-174
|
artikel
|
| 24 |
Trigger alerts associated with laboratory abnormalities on identifying potentially preventable adverse drug events in the intensive care unit and general ward
|
Buckley, Mitchell S.
|
|
2018
|
|
4 |
p. 207-217
|
artikel
|
| 25 |
Varenicline and cardiovascular adverse events: a perspective review
|
Chelladurai, Yohalakshmi
|
|
2014
|
|
4 |
p. 167-172
|
artikel
|
Tijdschrift beschrijving